Another study performed on late stage NSCLC patients gave comparable results, since CTCs showing both epithelial and mesenchymal markers in RNA-ISH assays negatively correlated with CD3+ and CD8+ T cells; moreover, CTC levels positively correlated with metastasis and a worse clinical outcome [30]. Here, CD8A is linked to non-small cell lung carcinoma.